STELLAR 303 Clinical Trial (Exelixis) | US Patient Website
Description
Learn more about STELLAR-303 â a new study for people with metastatic colon or rectal cancer. The combination of XL092 and atezolizumab has not been approved by the FDA. The safety and effectiveness of this treatment have not been established and are being studied as part of this clinical trial.